# Study to Assess the Inhibition of Plaque Formation in Subjects With a Gingival Index ≤1.5

> **NCT03378401** · PHASE3 · COMPLETED · sponsor: **Schülke & Mayr GmbH** · enrollment: 114 (actual)

## Conditions studied

- Inhibition of Plaque Formation (by Gingivitis-Index ≤1.5)

## Interventions

- **DRUG:** Octenidinedihydrochlorid
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT03378401
- **Lead sponsor:** Schülke & Mayr GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-11
- **Primary completion:** 2018-09-14
- **Final completion:** 2018-09-14
- **Target enrollment:** 114 (ACTUAL)
- **Last updated:** 2018-11-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03378401

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03378401, "Study to Assess the Inhibition of Plaque Formation in Subjects With a Gingival Index ≤1.5". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03378401. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*